The Pathophysiology of Paroxysmal Nocturnal Hemoglobinuria and Treatment With Eculizumab
Therapeutics and Clinical Risk Management
doi 10.2147/tcrm.s3334
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2009
Authors
Publisher
Informa UK Limited